Sessa Capital Im, L.P. Sab Biotherapeutics, Inc. Call Options Transaction History

Sessa Capital Im, L.P.

  • $2.4 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $133M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Sessa Capital Im, L.P. Portfolio

Follow Sessa Capital Im, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sessa Capital Im, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Sessa Capital Im, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email